Back
Acumen Pharmaceuticals 10K Form
Buy
52
ABOS
Acumen Pharmaceuticals
Last Price:
3.48
Seasonality Move:
68.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ABOS News And Ratings
See the #1 stock for the next 7 days that we like better than ABOS
ABOS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.44M |
|---|---|
| Cash Flow: | $-8.33M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.61 |
| Price / Book: | 0.78 |
Profitability
| EPS (TTM): | -1.09000 |
|---|---|
| Net Income (TTM): | $-52.37M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Acumen Pharmaceuticals Earnings Forecast
Key Acumen Pharmaceuticals Financial Ratios
- The Interest Expense is -1.11% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Acumen Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABOS |
| Website: | acumenpharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABOS Technical Analysis vs Fundamental Analysis
Buy
52
Acumen Pharmaceuticals (ABOS)
is a Buy
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a Buy
The current Acumen Pharmaceuticals [ABOS] share price is $3.48. The Score for ABOS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.